Published: 4 July 2018
Author(s): Nils Perrin, Angela Frei, Stephane Noble
Issue: July 2018
Section: Narrative Review

During the last 15 years, transcatheter aortic valve implantation (TAVI) has gained wide acceptance with good reproducible clinical and safety outcomes. Today, TAVI has not only overtaken conventional surgery as the standard of care for the treatment of patients with symptomatic aortic stenosis at high surgical risk, but can also be considered in selected intermediate-risk patients. This follows technological improvements, better patient assessment and increased operator experience leading to a significant reduction in most procedure-related complications and long-term mortality.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.